OLIG2 (Marker of Glial Brain Tumors) (OLIG2/2400), CF568 conjugate, 0.1mg/mL — image 1 of 3

Product details

OLIG2 (Marker of Glial Brain Tumors) (OLIG2/2400), CF568 conjugate, 0.1mg/mL

Catalog number BNC682400-500

Price for BNC682400-500

Size / count 1x 500 µL

About this product

Olig2, a basic helix-loop-helix transcription factor, is involved in oligodendroglial specification. Olig2 expression has been reported in most glial tumors, such as oligodendrogliomas and astrocytomas. Although more than half of glioblastomas are positive for Olig2, expression is very weak in terms of both percentage of labeled cells and intensity. No Olig2 expression has been found in the non-glial tumors including neuro-epithelial tumors, ependymomas, sub-ependymomas, medulloblastomas, and non-neuroepithelial tumors, such as CNS lymphomas, meningiomas, schwannomas, atypical teratoid / rhabdoid tumor, and haemangioblastomas. Compared to the strong staining seen in glioma samples, a weak expression is observed in non-tumoral brain tissue (gliosis) .Primary antibodies are available purified, or with a selection of fluorescent CF® Dyes and other labels. CF® Dyes offer exceptional brightness and photostability. Note: Conjugates of blue fluorescent dyes like CF®405S and CF®405M are not recommended for detecting low abundance targets, because blue dyes have lower fluorescence and can give higher non-specific background than other dye colors.

Specifications

Catalog number: BNC682400-500
Size / count: 1x 500 µL
Dry ice: No
Hazardous: No
Discontinued: No
CAS Number: 9007-83-4
Synonyms: Basic helix loop helix protein class B1 (bHLHB1) ; basic helix-loop-helix protein 19 (bHLHe19) ; OLIG2; Oligodendrocyte lineage transcription factor 2; Oligodendrocyte specific bHLH transcription factor 2; Oligodendrocyte transcription factor 2; Protein kinase C-binding protein 2 (PRKCBP2) ; RACK17
UNSPSC: 41116161
UNSPSC Description: Primary and secondary antibodies for multiple methodology immunostaining detection application
Gene Name: OLIG2
Gene ID: 10215
NCBI Gene ID: 176977
UniProt: Q13516
Swiss Prot: Q13516
Host: Mouse
Species Reactivity: Human
Reactivity: OLIG2
Immunogen: Recombinant fragment of human OLIG2 protein (around aa 1-141) (exact sequence is proprietary)
Target Antigen: OLIG2
Clonality: Monoclonal
Clone: OLIG2/2400
Type: Primary
Source: Animal
Origin: Animal
Applications: IHC, FFPE (verified)
Field of Research: Cancer, Neuroscience, Transcription factors
Positive Control: THP-1 cells. Astrocytoma
Stability: 2 years
Concentration: 0.1 mg/mL
Buffer: PBS, 0.1% BSA, 0.05% azide
Molecular Weight: 30-40 kDa
Shipping Conditions: RT (ND)
Storage Conditions: Stable at room temperature or 37°C (98°F) for 7 days.
Notes: Protect from light
Shelf Life: Guaranteed for at least 24 months from date of receipt when stored as recommended
Fragment: IgG1, kappa
Species: Mus musculus (mouse), BSA from bovine serum (Bos taurus) or recombinant BSA produced in Chinese hamster ovary cells.
Classification: 0.05% sodium azide (CAS 26628-22-8)
Conjugate: CF568

Frequently Asked Questions

What is the catalog number for OLIG2 (Marker of Glial Brain Tumors) (OLIG2/2400), CF568 conjugate, 0.1mg/mL?

The catalog number for OLIG2 (Marker of Glial Brain Tumors) (OLIG2/2400), CF568 conjugate, 0.1mg/mL is BNC682400-500.

What sizes are available for OLIG2 (Marker of Glial Brain Tumors) (OLIG2/2400), CF568 conjugate, 0.1mg/mL?

OLIG2 (Marker of Glial Brain Tumors) (OLIG2/2400), CF568 conjugate, 0.1mg/mL is available in the following size(s): 1x 500 µL.

Is OLIG2 (Marker of Glial Brain Tumors) (OLIG2/2400), CF568 conjugate, 0.1mg/mL in stock?

OLIG2 (Marker of Glial Brain Tumors) (OLIG2/2400), CF568 conjugate, 0.1mg/mL is currently made to order / not held in immediate stock. Contact us for lead time.

Who manufactures OLIG2 (Marker of Glial Brain Tumors) (OLIG2/2400), CF568 conjugate, 0.1mg/mL?

OLIG2 (Marker of Glial Brain Tumors) (OLIG2/2400), CF568 conjugate, 0.1mg/mL is manufactured by Biotium.

What is the estimated delivery time for OLIG2 (Marker of Glial Brain Tumors) (OLIG2/2400), CF568 conjugate, 0.1mg/mL?

Estimated delivery time for OLIG2 (Marker of Glial Brain Tumors) (OLIG2/2400), CF568 conjugate, 0.1mg/mL is approximately 15 business day(s), depending on your location.

Where can I find the safety data sheet (SDS/MSDS) for OLIG2 (Marker of Glial Brain Tumors) (OLIG2/2400), CF568 conjugate, 0.1mg/mL?

The safety data sheet for OLIG2 (Marker of Glial Brain Tumors) (OLIG2/2400), CF568 conjugate, 0.1mg/mL is available here: https://cdn.gentaur.com/products/37/68dd0297061270361e1003df/msds/bnc682400-500.pdf.

What is OLIG2 (Marker of Glial Brain Tumors) (OLIG2/2400), CF568 conjugate, 0.1mg/mL used for?

What is the molecular weight of the target protein?

Molecular weight information, where applicable, is listed on the datasheet under target details, useful for confirming the correct band on western blot.

How long will it take to receive this product if it’s custom made?

Lead times depend on the product type: custom polyclonal antibodies typically take 12-14 weeks, monoclonal antibodies 15-17 weeks, made-to-order recombinant proteins 4-8 weeks, and made-to-order recombinant antibodies 6-8 weeks. These are estimates and may shift due to production delays.

What is the recommended dilution for this antibody?

A recommended dilution range for each validated application is provided on the datasheet, but optimal dilution should be titrated for your specific experimental system, sample type, and detection method.